All Stories

  1. Central pain sensitivity is associated with changes in fatigue in rheumatoid arthritis: data from the CAP-RA study
  2. Rheumatoid arthritis and interstitial lung disease: the role of comorbidities. Retrospective analysis of two RA inception cohorts in the UK
  3. ESTABLISHING PROOF-OF-CONCEPT FOR THE PAIN-AT-WORK TOOLKIT: A DIGITAL INTERVENTION TO SUPPORT PEOPLE AT WORK WITH CHRONIC PAIN
  4. Comparative effectiveness of various exercise interventions on central sensitisation indices: A systematic review and network meta-analysis
  5. Central aspects of pain associated with physical activity: results from the Investigating Musculoskeletal Health and Wellbeing cohort
  6. The importance of central sensitization for clinical trials of disease modifying osteoarthritis drugs (DMOADs)
  7. The rat osteoarthritis bone score for histological pathology relevant to human bone marrow lesions and pain
  8. Validation of a questionnaire for central nervous system aspects of joint pain: the CAP questionnaire
  9. The association of painful and non-painful morbidities with frailty: a cross sectional analysis of a cohort of community dwelling older people in England
  10. The Web-Based Pain-at-Work Toolkit With Telephone Support for Employees With Chronic or Persistent Pain: Protocol for a Cluster Randomized Feasibility Trial
  11. Associations of Muscle Strength with Central Aspects of Pain: Data from the Knee Pain and Related Health in the Community (KPIC) Cohort
  12. The Web-Based Pain-at-Work Toolkit With Telephone Support for Employees With Chronic or Persistent Pain: Protocol for a Cluster Randomized Feasibility Trial (Preprint)
  13. The bidirectional relationship between chronic joint pain and frailty: data from the Investigating Musculoskeletal Health and Wellbeing cohort
  14. Inflammatory and Noninflammatory Disease Activity in Rheumatoid Arthritis: The Effect of Pain on Personalized Medicine
  15. Harmonising knee pain patient-reported outcomes: a systematic literature review and meta-analysis of Patient Acceptable Symptom State (PASS) and individual participant data (IPD)
  16. Influence of Social Support, Financial Status, and Lifestyle on the Disparity Between Inflammation and Disability in Rheumatoid Arthritis
  17. The osteoarthritis bone score (OABS): a new histological scoring system for the characterisation of bone marrow lesions in osteoarthritis
  18. An observational study of centrally facilitated pain in individuals with chronic low back pain
  19. Exploring the disparity between inflammation and disability in the 10-year outcomes of people with rheumatoid arthritis
  20. Fatigue in early rheumatoid arthritis: data from the Early Rheumatoid Arthritis Network
  21. A Systematic Review of the Biological Effects of Cordycepin
  22. The efficacy of systemic glucocorticosteroids for pain in rheumatoid arthritis: a systematic literature review and meta-analysis
  23. Central Aspects of Pain in Rheumatoid Arthritis (CAP-RA): protocol for a prospective observational study
  24. The Central Aspects of Pain in the Knee (CAP-Knee) questionnaire; a mixed-methods study of a self-report instrument for assessing central mechanisms in people with knee pain
  25. Bone marrow lesions are make an important contribution to osteoarthritic knee pain
  26. Don't judge a book (knee) by its cover (cartilage)
  27. Investigating musculoskeletal health and wellbeing in the UK
  28. Self-reported characteristics can help predict long-term knee pain.
  29. Different types of flares in people with rheumatoid arthritis
  30. Quantitative sensory testing and predicting outcomes for musculoskeletal pain, disability, and negative affect
  31. Specific nerves growing in the joint might be important in knee osteoarthritis pain
  32. Pain in people with rheumatoid arthritis follows different trajectories
  33. CGRP and Painful Pathologies Other than Headache
  34. Creating a tool to improve personalisation of osteoarthritis knee pain treatment.
  35. Using different measurements of rheumatoid arthritis activity to work out underlying causes of pain
  36. Analgesic effects of the cathepsin K inhibitor L-006235 in the monosodium iodoacetate model of osteoarthritis pain
  37. Reductions in Radiographic Progression in Early Rheumatoid Arthritis Over Twenty-Five Years: Changing Contribution From Rheumatoid Factor in Two Multicenter UK Inception Cohorts
  38. Risk prediction model for knee pain in the Nottingham community: a Bayesian modelling approach
  39. Responsiveness of SF-36 Health Survey and Patient Generated Index in people with chronic knee pain commenced on oral analgesia: analysis of data from a randomised controlled clinical trial
  40. People with RA can be divided into subgroups, based upon their pain levels and inflammation.
  41. Risk factors for pain in people with rheumatoid arthritis
  42. Osteoarthritis may be common in the hands and feet of people who have rheumatoid arthritis.
  43. A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis
  44. Self-reported adult footwear and the risks of lower limb osteoarthritis: the GOAL case control study
  45. Mechanisms, impact and management of pain in rheumatoid arthritis
  46. Work Disability and State benefit in people with early rheumatoid arthritis
  47. Increased function of pronociceptive TRPV1 at the level of the joint in a rat model of osteoarthritis pain
  48. Factors predicting change from the first DMARD treatment during early rheumatoid arthritis
  49. Pain in Rheumatoid Arthritis
  50. In search of better tools to measure pain in people with osteoarthritis
  51. Risk Factors for painful rheumatoid arthritis
  52. A role for the sensory neuropeptide calcitonin gene‐related peptide in endothelial cell proliferationin vivo
  53. Lymphatic vessels in osteoarthritic human knees
  54. History of knee injuries and knee osteoarthritis: a meta-analysis of observational studies
  55. Incident knee pain in the Nottingham community: a 12-year retrospective cohort study
  56. Occupational risk factors for osteoarthritis of the knee: a meta-analysis
  57. Nottingham knee osteoarthritis risk prediction models
  58. Lifetime body mass index, other anthropometric measures of obesity and risk of knee or hip osteoarthritis in the GOAL case-control study
  59. Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis
  60. Involvement of different risk factors in clinically severe large joint osteoarthritis according to the presence of hand interphalangeal nodes
  61. Mild acetabular dysplasia and risk of osteoarthritis of the hip: a case-control study
  62. Osteochondral angiogenesis and increased protease inhibitor expression in OA
  63. Self-reported knee and foot alignments in early adult life and risk of osteoarthritis
  64. Evaluation of a Photographic Chondropathy Score (PCS) for pathological samples in a study of inflammation in tibiofemoral osteoarthritis
  65. Angiogenesis in two animal models of osteoarthritis
  66. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis
  67. Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis
  68. Tachykinins and the Cardiovascular System
  69. The Biological and Therapeutic Importance of Gastrin Gene Expression in Pancreatic Adenocarcinomas
  70. Combined effect of bradykinin B2 and neurokinin-1 receptor activation on endothelial cell proliferation in acute synovitis.
  71. Inflammation and angiogenesis in osteoarthritis
  72. Expression and Regulation of Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinases by Intestinal Myofibroblasts in Inflammatory Bowel Disease
  73. Potential role of endocrine gastrin in the colonic adenoma carcinoma sequence
  74. Antibodies raised against the extracellular tail of the CCKB/gastrin receptor inhibit gastrin-stimulated signalling
  75. Transforming growth factor-α-mediated growth pathways in human gastro-intestinal cell lines in relation to the gastrin autocrine pathway
  76. Coexpression of gastrin and gastrin receptors (CCK-B and Delta CCK-B) in gastrointestinal tumour cell lines